Nanalysis Scientific Corp.

TSXV:NSCI Voorraadrapport

Marktkapitalisatie: CA$45.2m

De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

Nanalysis Scientific Balans Gezondheid

Financiële gezondheid criteriumcontroles 2/6

Nanalysis Scientific has a total shareholder equity of CA$24.2M and total debt of CA$14.7M, which brings its debt-to-equity ratio to 61%. Its total assets and total liabilities are CA$51.5M and CA$27.3M respectively.

Belangrijke informatie

61.0%

Verhouding schuld/eigen vermogen

CA$14.75m

Schuld

Rente dekkingsration/a
ContantCA$1.13m
AandelenCA$24.17m
Totaal verplichtingenCA$27.29m
Totaal activaCA$51.45m

Recente financiële gezondheidsupdates

Recent updates

Nanalysis Scientific Corp.'s (CVE:NSCI) CEO Will Probably Find It Hard To See A Huge Raise This Year

Jun 19
Nanalysis Scientific Corp.'s (CVE:NSCI) CEO Will Probably Find It Hard To See A Huge Raise This Year

Nanalysis Scientific Corp. (CVE:NSCI) Stock Catapults 29% Though Its Price And Business Still Lag The Industry

May 12
Nanalysis Scientific Corp. (CVE:NSCI) Stock Catapults 29% Though Its Price And Business Still Lag The Industry

Benign Growth For Nanalysis Scientific Corp. (CVE:NSCI) Underpins Stock's 25% Plummet

Mar 24
Benign Growth For Nanalysis Scientific Corp. (CVE:NSCI) Underpins Stock's 25% Plummet

Nanalysis Scientific Corp. (CVE:NSCI) Shares Fly 43% But Investors Aren't Buying For Growth

Feb 08
Nanalysis Scientific Corp. (CVE:NSCI) Shares Fly 43% But Investors Aren't Buying For Growth

We Think Nanalysis Scientific (CVE:NSCI) Has A Fair Chunk Of Debt

Jan 31
We Think Nanalysis Scientific (CVE:NSCI) Has A Fair Chunk Of Debt

Would Nanalysis Scientific (CVE:NSCI) Be Better Off With Less Debt?

Aug 26
Would Nanalysis Scientific (CVE:NSCI) Be Better Off With Less Debt?

Nanalysis Scientific Corp.'s (CVE:NSCI) Price Is Right But Growth Is Lacking

Apr 17
Nanalysis Scientific Corp.'s (CVE:NSCI) Price Is Right But Growth Is Lacking

Is Nanalysis Scientific (CVE:NSCI) Using Too Much Debt?

Dec 08
Is Nanalysis Scientific (CVE:NSCI) Using Too Much Debt?

Is Nanalysis Scientific (CVE:NSCI) Weighed On By Its Debt Load?

Jul 15
Is Nanalysis Scientific (CVE:NSCI) Weighed On By Its Debt Load?

Health Check: How Prudently Does Nanalysis Scientific (CVE:NSCI) Use Debt?

Jan 24
Health Check: How Prudently Does Nanalysis Scientific (CVE:NSCI) Use Debt?

Is Nanalysis Scientific (CVE:NSCI) Using Debt Sensibly?

Mar 29
Is Nanalysis Scientific (CVE:NSCI) Using Debt Sensibly?

Nanalysis Scientific (CVE:NSCI) Has Debt But No Earnings; Should You Worry?

Dec 14
Nanalysis Scientific (CVE:NSCI) Has Debt But No Earnings; Should You Worry?

Analyse van de financiële positie

Kortlopende schulden: NSCI's short term assets (CA$17.7M) exceed its short term liabilities (CA$12.5M).

Langlopende schulden: NSCI's short term assets (CA$17.7M) exceed its long term liabilities (CA$14.8M).


Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: NSCI's net debt to equity ratio (56.4%) is considered high.

Schuld verminderen: NSCI's debt to equity ratio has increased from 7.6% to 61% over the past 5 years.


Balans


Analyse van de cashflow

Voor bedrijven die in het verleden gemiddeld verliesgevend zijn geweest, beoordelen we of ze ten minste 1 jaar kasstroom hebben.

Stabiele cash runway: NSCI has less than a year of cash runway based on its current free cash flow.

Voorspelling contante baan: NSCI has less than a year of cash runway if free cash flow continues to reduce at historical rates of 37.8% each year


Ontdek gezonde bedrijven